Journal History

2012 The inaugural issue was released. Antibiotics was published as a quarterly journal.
2015 The journal Twitter account was established.
2016 Antibiotics was indexed in Emerging Sources Citation Index (ESCI)—Web of Science (Clarivate Analytics), starting with Volume 1 (Issue 1).
Antibiotics was indexed in PubMed—National Library of Medicine (NLM), starting with Volume 1 (Issue 1).
Antibiotics was indexed in PubMed Central (PMC)—National Library of Medicine (NLM), starting with Volume 1 (Issue 1).
Antibiotics was indexed in Scopus (Elsevier), starting with Volume 1 (Issue 1).
2017 Antibiotics announced the first edition of the Travel Award.
2018 Antibiotics was indexed in Science Citation Index Expanded (SCIE)—Web of Science (Clarivate Analytics), starting with Volume 1 (Issue 1).
2019

Antibiotics received its first Impact Factor (2.921), ranked 40/89 (Q2) in “Infectious Diseases” and 109/267 (Q2) in “Pharmacology & Pharmacy”.

Antibiotics established the following sections:
Antibiotics Use and Antimicrobial Stewardship;
Novel Antimicrobial Agents;
Antimicrobial Peptides;
Biosynthesis and Combinatorial Approaches in Antimicrobial Discovery;
Mechanism and Evolution of Antibiotic Resistance;
Fungi and Their Metabolites;
Pharmacokinetics and Pharmacodynamics of Drugs;
Plant-Derived Antibiotics;
Mechanisms of Antibiotic Action;
Structures of Bacterial Proteins;
Biochemical and Genetics Studies of Infectious Disease Progression and Intervention;
Bacteriophages;
The Global Need for Effective Antibiotics.

Antibiotics started the Topic Board.

2020

Antibiotics received an Impact Factor (3.893), ranked 23/93 (Q1) in “Infectious Diseases” and 64/270 (Q1) in “Pharmacology & Pharmacy”.

Antibiotics adopted a monthly publication schedule.

Antibiotics started the Reviewer Board.

Antibiotics announced the first edition of the Best Paper Award, Reviewer Award and Young Investigator Award.

2021

Antibiotics received an Impact Factor (4.639), ranked 26/92 (Q2) in “Infectious Diseases” and 75/275 (Q2) in “Pharmacology & Pharmacy”.

Antibiotics established the following sections:
Antibiotic Therapy in Infectious Diseases;
Antimicrobial Materials and Surfaces;
Antibiofilm Strategies;
Antibiotics in Animal Health.

2022

The year 2022 marked the 10th Anniversary of Antibiotics.

2023

Structures of Bacterial Proteins was merged with Mechanisms of Antibiotic Action to create a new section Mechanisms and Structural Biology of Antibiotic Action.

Biochemical and Genetics Studies of Infectious Disease Progression and Intervention was renamed as Genetic and Biochemical Studies of Antibiotic Activity and Resistance.

Editor-in-Chief

2012–2019 Editor-in-Chief: Prof. Dr. Christopher C. Butler
2019–present Editor-in-Chief: Prof. Dr. Nicholas Dixon

Section Editor-in-Chief

2019–present Section Editor-in-Chief: Dr. Albert Figueras for the section on Antibiotics Use and Antimicrobial Stewardship.
Section Editor-in-Chief:
Prof. Dr. Jeffrey Lipman for the section on Pharmacokinetics and Pharmacodynamics of Drugs.
Section Editor-in-Chief:
Prof. Dr. Carlos M. Franco for the section on Novel Antimicrobial Agents.
Section Editor-in-Chief:
Dr. Jean-Marc Sabatier for the section on Antimicrobial Peptides.
Section Editor-in-Chief:
Prof. Dr. John E. Gustafson for the section on Mechanism and Evolution of Antibiotic Resistance.
Section Editor-in-Chief:
Prof. Dr. William N. Setzer for the section on Plant-Derived Antibiotics.
Section Editor-in-Chief:
Prof. Dr. Anthony William Coleman for the section on Mechanisms of Antibiotic Action.
2019–2024 Section Editor-in-Chief: Prof. Dr. Jesus Simal-Gandara for the section on The Global Need for Effective Antibiotics.
2020–present Section Editor-in-Chief: Prof. Dr. Adelaide Almeida for the section on Bacteriophages.
2021–present Section Editor-in-Chief: Dr. Manuel Simões for the section on Biosynthesis and Combinatorial Approaches in Antimicrobial Discovery.
Section Editor-in-Chief:
Prof. Dr. Max Maurin for the section on Antibiotics in Animal Health.
Section Editor-in-Chief:
Dr. Wolf-Rainer Abraham for the section on Antibiofilm Strategies.
Section Editor-in-Chief:
Prof. Dr. Anders Løbner-Olesen for the section on Genetic and Biochemical Studies of Antibiotic Activity and Resistance.
2021–2023

Section Editor-in-Chief: Prof. Dr. Aaron J. Oakley for the section on Structures of Bacterial Proteins.
Section Editor-in-Chief:
Prof. Dr. Anthony William Coleman for the section on Mechanisms of Antibiotic Action.

2022–present Section Editor-in-Chief: Dr. Serena Riela for the section on Antimicrobial Materials and Surface.
Section Editor-in-Chief:
Dr. Mehran Monchi for the section on Antibiotic Therapy in Infectious Diseases.
2023–present Section Editor-in-Chief: Prof. Dr. Anthony William Coleman for the section on Mechanisms and Structural Biology of Antibiotic Action.
2023–2024 Section Editor-in-Chief: Prof. Dr. Shiping Tian for the section on Fungi and Their Metabolites.
2024–present Section Editor-in-Chief: Dr. Krisztina M. Papp-Wallace for the section on Mechanism and Evolution of Antibiotic Resistance.
 
Back to TopTop